FORT MYERS, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced that Anne Marie Rainey, AON’s director of value-based care, has been appointed to the Association of Cancer Care Centers’ Board of Trustees. As director of value-based care at AON, Rainey manages internal quality, government, and value-based care initiatives. She has experience in government quality reporting as a contractor for the Centers f ...

Core Insights - MidAmerica Cancer Care (MACC) has opened a new medical oncology clinic in Kansas City, Kansas, enhancing cancer care for the local community [1][3] - The new clinic features private exam rooms, an infusion room, in-house lab and pathology services, and a specialty pharmacy for oral oncolytics [2] - MACC emphasizes a patient-first approach, providing personalized care and treatment plans tailored to individual needs [3][9] Company Overview - MACC is a community-based oncology practice established in 2019, dedicated to providing compassionate cancer care [9] - The practice operates with a team of six physicians and 16 advanced practitioners, focusing on treating the whole patient [10] - MACC has partnered with American Oncology Network (AON) to enhance patient care and expand service offerings [4][6] Partnership and Services - The partnership with AON allows MACC to provide additional services, including access to an in-house specialty pharmacy with home delivery options [4] - AON represents over 290 providers across 21 states, focusing on value-based care and improving patient outcomes [6][8] - AON is committed to health equity, addressing disparities in cancer care to ensure all patients have access to necessary treatments [8]

Company Overview - American Oncology Network, Inc. is a microcap healthcare stock trading on an OTC exchange, relatively unknown among analysts and investors [1] Analyst Background - Robert F. Abbott has been managing his family's investments since 1995 and has experience with options since 2010, focusing on covered calls and collars with long stocks [2]

Revenue Growth and Market Size - Revenue has grown at a roughly 41% CAGR from 2019 to 2024[37] - The global community oncology services market size is expected to grow to $81.33 billion in 2027 at a CAGR of 10.9%[22] - The oncology pharmaceuticals market is currently a $177 billion industry and is expected to grow to $314 billion by 2026[22] - The oncology service market is expected to grow five times faster than the population growth through 2040, with over 12,000 oncologists in the U.S., 76% of whom work in practices with 1-5 oncologists[50] Company Operations and Expansion - As of December 31, 2024, the company was active across 37 practices in 20 states and the District of Columbia[22] - The company anticipates adding more managed practices in the future through acquisitions and organic growth[40] - The company launched a new AON Pharmacy MSA model in December 2022 to offer potential AON practices access to pharmaceutical management[44] - The company plans to expand its national research platform to offer access to cutting-edge clinical trials within the community setting[46] - The average managed clinic size is 6,200 square feet, typically accommodating up to 30 providers, with flexibility to establish smaller clinics as needed[55] Financial Strategies and Revenue Streams - New revenue streams are being developed from clinical informatics and data licensing subscriptions, alongside the implementation of new CMS-approved patient services[51] - The company plans to pursue accelerated growth through a more aggressive M&A strategy, leveraging access to public markets to broaden potential targets[51] Quality and Compliance - The company maintains a 96% Physician Quality Score according to CMMI[41] - The company competes favorably on patient experience, quality of care, health outcomes, total cost of care, brand identity, and trust within its served markets[56] - Compliance with extensive government regulations is critical, as failure to comply could result in significant penalties and loss of ability to participate in Medicare and Medicaid[59] - The company has developed a HIPAA compliance plan to address privacy and security regulations, which impose significant costs[80] Labor and Employment - The company employed approximately 1,914 employees as of December 31, 2024, including 266 physicians and advanced practice providers[87] - Rising labor costs are a significant challenge, necessitating enhanced wages and benefits to recruit and retain healthcare providers[88] Insurance and Liability - The company maintains professional malpractice liability insurance and general liability insurance, but coverage may not be sufficient for all claims[86] Regulatory Environment - The Affordable Care Act (ACA) has significantly impacted healthcare delivery and reimbursement, with ongoing challenges affecting its implementation[73] - Medicare payments to providers are subject to a 2% reduction per fiscal year from 2013 to 2030, with variations in actual reductions from 1% to 3% depending on the fiscal year[75] - The company is evaluating the potential impact of the Inflation Reduction Act of 2022 on its business, particularly regarding drug pricing and Medicare[75] - The 21st Century Cures Act has transformed data interoperability and information sharing requirements, which could materially affect the company's operations[76] Environmental and Property Management - The company is subject to various federal, state, and local environmental laws, but current compliance does not materially affect financial results or operations[89] - The company leases 102 properties for practice locations and administrative facilities, with an average practice occupying 6,000 square feet[91] Payment Models - The implementation of ASP-based reimbursement has reduced differential pricing available from pharmaceutical manufacturers, impacting competitive strengths[49] - The company is exploring alternative payment models, including value-based arrangements, which may not produce as much initial revenue but allow for market expansion[52] Payor Relationships - The company maintains strong relationships with payors, managing contracts on a state-by-state basis, ensuring no single payor contract accounts for a majority of revenue[53]

Core Viewpoint - Woodlands Cancer Institute has relocated its medical oncology clinic to a new address in The Woodlands, Texas, to enhance cancer care services for the community [1][3]. Company Overview - Woodlands Cancer Institute is a community-based practice that provides medical oncology, radiation oncology, and hematology services for patients diagnosed with various types of cancer and blood disorders [8]. - The institute emphasizes compassionate care centered around the patient, aiming to deliver the best possible experience throughout the healthcare journey [8]. New Clinic Features - The new medical oncology clinic includes additional private exam rooms, an infusion room, in-house lab and pathology services, and a specialty pharmacy for oral oncolytics [2]. - The relocation allows for expanded patient services and therapeutics, as well as a larger space for additional staff to prioritize patient health and well-being [5]. Partnership and Network - Woodlands Cancer Institute is a partner of American Oncology Network (AON), which is one of the fastest-growing community-based oncology networks in the U.S. [4][7]. - AON provides additional patient care services, including access to an in-house specialty pharmacy with home delivery of certain medications [4]. Commitment to Patient Care - The practice maintains high standards of patient care, ensuring personalized treatment plans tailored to individual patient needs [3]. - AON is committed to promoting health equity and addressing disparities in cancer care, ensuring all patients have access to necessary care for optimal health outcomes [7].

Core Insights - American Oncology Network (AON) has launched LabVizor, a cloud-based anatomic pathology laboratory information system (LIS) developed by SigmaCore, aimed at enhancing efficiency in pathology and oncology labs [1][2] - LabVizor is designed to meet the unique needs of oncologists and pathologists, integrating complex pathology reports into a streamlined system [2][3] - The platform is fully integrated with AON's electronic medical record (EMR) system, allowing for bidirectional data exchange and improving clinical decision-making [3] Company Overview - AON is one of the fastest-growing community oncology networks in the U.S., representing over 290 providers across 21 states since its founding in 2018 [5][6] - SigmaCore is a pathology practice management consultancy focused on empowering pathologists and optimizing pathology practices [7][8] Product Features - Key features of LabVizor include Pre-Accessioning for workflow planning, Integrated Reporting for seamless diagnostic information presentation, and a User-Friendly Dashboard for comprehensive lab operations monitoring [4][5] - LabVizor also offers Data Analytics for generating data-driven reports and Collaboration Tools for effective workflow management among team members [4][5] Strategic Goals - AON aims to leverage advanced technology like LabVizor to enhance cancer care, improve diagnostic accuracy, and ensure patient-centered services [4][6] - The integration of LabVizor aligns with AON's mission to expand access to high-quality cancer care in local communities [4][6]

Core Insights - Florida Oncology and Hematology (FOH) has welcomed Dr. Michele Ramirez, a board-certified medical oncologist and hematologist, to its physician care team, enhancing its capacity to provide patient-centered cancer care in Naples, Florida [1][4]. Company Overview - Florida Oncology and Hematology specializes in the diagnosis and treatment of cancer and blood disorders, serving patients in multiple locations including Cape Coral, Clearwater, Fort Myers, and Naples, Florida [6]. - The practice is committed to delivering innovative cancer care based on research and evidence-based medicine, offering a comprehensive range of services including diagnosis, treatment, clinical trials, survivorship, and patient support [3][6]. Team Expansion - With the addition of Dr. Ramirez, the FOH team now consists of eight medical oncologists and ten advanced practice providers across five locations in Florida [3]. - Dr. Ramirez brings over 20 years of experience in oncology and hematology, having practiced in Florida since 2002, and is dedicated to providing high-quality, patient-centered care [2][3]. Organizational Commitment - American Oncology Network (AON), the partner organization of FOH, focuses on ensuring the long-term success of community oncology through innovative healthcare solutions and a physician-led model [5]. - AON aims to promote health equity by addressing disparities in cancer care and ensuring all patients have access to necessary treatments for optimal health outcomes [5].

Core Insights - MidAmerica Cancer Care (MACC) has joined the American Oncology Network (AON), enhancing its capabilities in patient-focused services and clinical trials [1][2][4] Company Overview - MACC, established in 2019, provides community-based oncology services in Kansas City and western Missouri, staffed by six Board-certified medical oncologists and 16 advanced practitioners [3][7][8] - The organization focuses on comprehensive cancer care, including diagnostics, treatment, clinical trials, survivorship programs, and patient support, all aimed at reducing travel burdens for patients [3][8] Partnership Details - The collaboration with AON allows MACC to expand its service offerings and improve patient outcomes while maintaining a patient-centered approach [2][3] - AON, founded in 2018, represents over 290 providers across 21 states and aims to enhance community oncology through innovative healthcare solutions and value-based care [5][6] Strategic Goals - The partnership supports AON's mission to expand access to high-quality cancer care in local communities and demonstrates its ability to collaborate with physician groups and hospital systems [4][6] - Both organizations are committed to promoting health equity and addressing disparities in cancer care [6]

Core Insights - Florida Oncology and Hematology has relocated its clinic in Fort Myers to a new state-of-the-art facility to enhance cancer care for the community [1][3] - The new clinic features 12 exam rooms, nearly 30 infusion chairs, an onsite lab, and a specialty pharmacy for oral oncolytics [1][2] - The practice is part of the American Oncology Network, which supports community-based oncology practices and provides additional patient care services [4][6] Company Overview - Florida Oncology and Hematology specializes in the diagnosis and treatment of cancer and blood disorders, serving patients in Cape Coral, Clearwater, Fort Myers, and Naples [8] - The practice emphasizes personalized care and treatment plans tailored to individual patient needs, ensuring high-quality treatment in a comfortable environment [3][8] - American Oncology Network, founded in 2018, is rapidly expanding with over 290 providers across 21 states, focusing on value-based care and improving patient outcomes [6][7] Services and Facilities - The new Fort Myers location includes private exam rooms for patient-physician discussions, an infusion room, in-house lab and pathology services, and an onsite specialty pharmacy [2][5] - The relocation allows for expanded patient services and therapeutics, as well as a larger space for staff to provide one-on-one care [5] - AON provides integrated revenue-diversifying ancillary services and practice management expertise to support independent physicians [7]

Company Announcement - American Oncology Network (AON) appoints Charlie Goddard as General Counsel [1] - Goddard brings over 15 years of legal experience in healthcare law, corporate governance, and compliance, with expertise in fraud and abuse prevention, data privacy, cybersecurity, dispute resolution, and high-stakes commercial transactions [2] - Goddard previously held positions at an AmLaw 100 firm and served as General Counsel for a leading orthopedic surgery group [3] Leadership Perspective - AON's CEO, Todd Schonherz, highlights Goddard's healthcare expertise as a perfect fit for the role, emphasizing his deep knowledge of health law as invaluable for AON's growth [2] - AON's Chief Medical Officer, Stephen "Fred" Divers, MD, notes that Goddard's expertise will help navigate the evolving healthcare landscape and advance strategic initiatives [3] Company Overview - AON is an alliance of physicians and healthcare leaders focused on ensuring the long-term success of community oncology and other specialties [5] - Founded in 2018, AON's network includes over 290 providers across 21 states, pioneering innovative healthcare solutions through a physician-led model [5] - AON promotes health equity by addressing disparities in cancer care and ensuring access to quality care for all patients [5] Mission and Vision - AON's mission is to make cancer care affordable and accessible in communities across the country [3] - The company focuses on value-based care, improving patient outcomes while reducing costs and expanding access to quality care [5] - AON is committed to shaping the future of community oncology through innovation and collaboration [6]